AbbVie Reports Second-Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Nasdaq, S&P 500 slip from record highs as yields and oil rebound
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
AbbVie (ABBV) Tops Q2 EPS by 6c, Revenue Beats, Updates FY Guidance
July 26, 2019 7:44 AM EDTAbbVie (NYSE: ABBV) reported Q2 EPS of $2.26, $0.06 better than the analyst estimate of $2.20. Revenue for the quarter came in at $8.26 billion versus the consensus estimate of $8.1 billion.
GUIDANCE:
AbbVie sees FY2019 EPS of $8.82-$8.92, versus the consensus of... More



